- Congresses
- IMCAS Asia - June 2025
- IMCAS China - July 2025
- IMCAS World Congress - January 2026
- IMCAS Americas - March 2026
- IMCAS Asia - June 2026
- Masterclasses
- IMCAS India - November 2025
- Congresses
- IMCAS Asia - June 2025
- IMCAS China - July 2025
- IMCAS World Congress - January 2026
- IMCAS Americas - March 2026
- IMCAS Asia - June 2026
- Masterclasses
- IMCAS India - November 2025

IMCAS Academy

Introduction
Register
Program
Speakers
Plan your trip
Submit an abstract
Sponsor list
Press

IMCAS China 2025
Program

Industry sponsored lectures

Room: Open Stage
Date: Saturday 12 July 2025 at 11:00 to 16:30
Format: OPEN STAGE TALK > oral presentations recorded on a dedicated stage within the exhibition area

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
11:00	Fabin SHEN	SHANGHAI MAY SKIN - AI for Aesthetic Growth: How Skin Analysis Drives Precision Treatment and Clinic High Conversion		147858
11:15	Virginie COUTURAUD	DIOR - The reverse Aging science for beauty		147859
11:30	Dr Elena RAZUMOVSKAYA	LOTOS UNITED - Hybrid treatment protocols in different morphotypes of facial ageing: PLLA and HA fillers		147860
11:45	Dr Wenhui CHEN	TO BE ANNOUNCED		147861
13:45	Prof Gaoyun YANG	OBAGI - TO BE ANNOUNCED		147869
14:00	Prof Gaoyun YANG	OBAGI - TO BE ANNOUNCED		147870
14:15	Hualong YU	GE HEALTHCARE - Vscan Air™ launches a new era of visual aesthetics		147871
14:30	Prof Olga KAPULER	LOTOS UNITED - The potential of PLLA and uncrosslinked HA in collagen stimulation programs		147872
14:45	Dr Natalia KALASHNIKOVA	LOTOS UNITED - The reasonable approach of combination EBDs and PLLA in aesthetic medicine		147873
15:00	Dr Qing ZHAO	FIMAN BIOTECHNOLOGY - The Renaissance of Animal-Derived Collagen Fillers in China: A Perfect Storm of Innovation and Demand		147874
15:15	Di ZONG	LABORATOIRES VIVACY - Yield stress and plastic domain as innovative rheological parameters for characterization of crosslinked hyaluronic acid hydrogels and clinical application potential		147875
15:30	Lei HAN	UNILEVER - Beauty and Wellbeing Science and Technology		147876
15:45	Xuelan GU	UNILEVER - Pioneering Research Revealing the Importance of Stress in Relation to Skin and Hair Well-being		147877
16:00	Dr Chengfeng ZHANG	UNILEVER - The Power of Multi-Vitamin to Restore the Stressed Skin and Aging		147878
16:15	Dr Fengjuan TU	UNILEVER - ExoBooster: Lactobacillus Exosomes for Skin-rejuvenating		147879

Go to previous session

Go to next room (Lunch Station)

Fabin SHEN

Industry Representative

China

Other author(s) :

SHANGHAI MAY SKIN - AI for Aesthetic Growth: How Skin Analysis Drives Precision Treatment and Clinic High Conversion

Virginie COUTURAUD

Pharmacist

France

Other author(s) :

DIOR - The reverse Aging science for beauty

Dr Elena RAZUMOVSKAYA

Plastic Surgeon

Russia

Other author(s) :

LOTOS UNITED - Hybrid treatment protocols in different morphotypes of facial ageing: PLLA and HA fillers

Objectives: This presentation will focus on treatment protocols and techniques for the combined use of HA fillers and PLLA, tailored to different facial aging morphotypes. It will explore product selection, injection strategies, and procedural nuances to achieve natural and harmonious rejuvenation.

Introduction: The combined use of hyaluronic acid (HA) fillers and poly-L-lactic acid (PLLA) presents a promising approach to addressing anatomical disproportions and age-related changes. Traditionally, these products are applied separately in distinct anatomical zones and tissue layers; however, integrating them within a single treatment session can enhance results, providing optimal and long-lasting outcomes.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): Lotos United

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: Lotos United

Dr Wenhui CHEN

Dermatologist

China

Other author(s) :

TO BE ANNOUNCED

Objectives: This course will provide participants with a comprehensive understanding of the core elements and strategies for integrating physician intellectual property (IP) development with clinical device applications. Participants will learn to establish an effective system for personal brand building and clinical technology application.

Introduction: In today's rapidly developing medical aesthetics industry, building a doctor's personal brand has become a key way to increase industry influence and commercial value. This report aims to deeply explore practical strategies for integrating doctor IP with clinical devices. Through case studies of successful IP development, the report reveals how to leverage clinical experience, academic achievements, online traffic management, and brand collaborations to create an IP with an international perspective.

Materials / method: First, to successfully build a doctor's IP, it is necessary to lay a solid professional foundation. Next, focus on online operational strategies and establish a data-driven mindset. Regularly analyze platform data, patient feedback, and market trends to optimize content strategies and commercial cooperation models continuously. By following a systematic IP development path, doctors can enhance their personal brand influence and drive the innovative application of medical technology, ultimately achieving dual enhancement of their professional and commercial value.

Results: Doctors can develop a clear roadmap for their IP development by clearly defining the positioning, model, and team and resource integration of medical aesthetics care companies. Each step must be carefully planned and steadily implemented, from the short-term deepening of the Asian skin database and incubation of a doctor IP matrix to the mid-term launch of co-branded care lines and establishment of an online and offline service network, and finally to the long-term goal of becoming the standard-setter for Asian skin anti-aging and promoting the globalization of medical IP.

Conclusion: Developing a doctor IP requires a systematic approach that focuses on four core elements: clinical experience, brand partnerships, online traffic management, and the latest clinical data. With continuous effort and innovation, a doctor IP's professionalism, commercial value, and market influence can be enhanced.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Prof Gaoyun YANG

Dermatologist

China

Other author(s) :

OBAGI - TO BE ANNOUNCED

Prof Gaoyun YANG

Dermatologist

China

Other author(s) :

OBAGI - TO BE ANNOUNCED

Hualong YU

Industry Representative

China

Other author(s) :

GE HEALTHCARE - Vscan Air™ launches a new era of visual aesthetics

Prof Olga KAPULER

Dermatologist

Russia

Other author(s) :

LOTOS UNITED - The potential of PLLA and uncrosslinked HA in collagen stimulation programs

Objectives: In the present study, we are aimed at creating a hybrid protocol, combining the application injectable poly-L-lactic acid and hyaluronic acid. The protocol has to meet the requirements safety, effecacy, and predictability of clinical results.

Introduction: There are pathological conditions, including scars and striae, as well as normal physiological processes, such as aging, associated with changes in the quality and quantity of collagen fibres in the skin. The possibility of predictable bioregulation of new collagen fibres production is a challenge that both manufacturers of collagen stimulators and dermatologists face whit.

Materials / method: Poly-L-lactic acid and uncrosslinked high molecular weight hyaluronic acid were injected in one zone, at one level, to a certain depth and within one treatment session. Dynamic monitoring was conducted for 6 weeks. Ultrasound study and histological examination of skin biopsies were used to estimate the result of the treatment.

Results: We revealed a common trend including reduction in rehabilitation period and achievement of positive clinical results witch took less time in comparison with the patients who were treated with according to a mono protocol eather whit poly-l-lactic acid or hyaluronic acid . The treatment with a combined protocol allowed as to reduce the number of patients’s visits to the clinic and to get a high level of patients’s satisfaction.

Conclusion: Hybrid protocols combining the application of injectable poly-L-lactic acid and hyaluronic acid are characterized by safety and hight predictable performance.

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): LOTOS UNITED

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): LOTOS UNITED

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: LOTOS UNITED

Dr Natalia KALASHNIKOVA

Dermatologist

Russia

Other author(s) :

LOTOS UNITED - The reasonable approach of combination EBDs and PLLA in aesthetic medicine

Dr Qing ZHAO

China

Other author(s) :

FIMAN BIOTECHNOLOGY - The Renaissance of Animal-Derived Collagen Fillers in China: A Perfect Storm of Innovation and Demand

Di ZONG

Industry Representative

China

Other author(s) :

LABORATOIRES VIVACY - Yield stress and plastic domain as innovative rheological parameters for characterization of crosslinked hyaluronic acid hydrogels and clinical application potential

Objectives: Yield stress as an innovative parameter for the rheological characterization of cross-linked hydrogel

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: VIVACY

Lei HAN

Industry Representative

China

Other author(s) :

UNILEVER - Beauty and Wellbeing Science and Technology

Xuelan GU

Industry Representative

China

Other author(s) :

UNILEVER - Pioneering Research Revealing the Importance of Stress in Relation to Skin and Hair Well-being

Dr Chengfeng ZHANG

Dermatologist

China

Other author(s) :

UNILEVER - The Power of Multi-Vitamin to Restore the Stressed Skin and Aging

Dr Fengjuan TU

PhD - Research

China

Other author(s) :

UNILEVER - ExoBooster: Lactobacillus Exosomes for Skin-rejuvenating

Objectives: 乳酸菌外泌体在皮肤修护领域的应用

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

CONGRESS in

0 1 0

DAYS IN SHANGHAI

You have a question?

Quickly find your answer in our FAQ

Congresses

IMCAS Asia
IMCAS China
IMCAS World Congress
IMCAS Americas
IMCAS Asia

About

Company
Privacy Policy
Legal information

Academy

Home
Courses
Webinars
Explore
Blog

Grant

Educational grant

Get in touch

Username/Email

Password

Keep me logged in

Forgot password ? Do not have an account yet? Sign up now

Keep me logged in

academy.Do_not_have_an_account_yet Sign up now

IMCAS China 2025 Program

Industry sponsored lectures

Lectures of the session

IMCAS China 2025
Program